Organization · Venture Capital
Cephalo Ventures
Cephalo Ventures is a venture capital organization focused on early-stage biotech startups in the United States and the United Kingdom, investing in therapeutics, synthetic biology, and medical devices.
Overview
What Cephalo Ventures does
What Cephalo Ventures is
Cephalo Ventures is a venture capital organization focused on early-stage biotech startups in the United States and the United Kingdom, investing in therapeutics, synthetic biology, and medical devices.
How it participates in the startup ecosystem
The current public profile supports funder and program host capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder · Program host
- Last reviewed
- May 3, 2026
Official channels
Find Cephalo Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Cephalo Ventures as a funder
Investment thesis
Cephalo Ventures focuses on rigorous science becoming investable products that can change healthcare outcomes, supporting scientists in developing therapeutics, synthetic biology, and medical devices.
Focus narrative
Cephalo Ventures specializes in early-stage biotech investments, focusing on pre-seed to Series A funding stages. The organization provides funding typically ranging from $150,000 to $300,000 and operates the Transferase Accelerator, a program designed to assist biotech startups with fundraising through workshops and access to a network of investors.
Value beyond capital
Cephalo Ventures adds value to its portfolio companies through its Transferase Accelerator program, which provides workshops and access to a network of biotech investors, helping startups refine their fundraising strategies and connect with potential partners.
Terms and economics
- Typical check
- $100,000–$300,000
- Sweet spot
- $150,000
Focus and fit
- Stages
- Pre-seed · Seed · Series A
- Sectors
- Biotech · Synthetic Biology · Medical Devices
- Regions
- United StatesUnited Kingdom
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 4
Portfolio context
Boston Bioprocess: Offers fermentation and downstream processing services at benchtop and pilot scale. Oxford SimCell: Develops vaccine technology using genome-sheared, non-dividing bacterial cells for antimicrobial-resistant pathogens. RiverWalk Therapeutics: A preclinical oncology company focused on developing adenosine A2B receptor antagonists. Imaginostics: A health tech startup working on quantitative MRI biomarkers for medical imaging.
Capability profile
Cephalo Ventures as a program host
Program thesis
Cephalo Ventures supports scientific research and innovation, focusing on investments that positively impact society through advancements in therapeutics, synthetic biology, and medical devices.
Focus narrative
Cephalo Ventures invests in early-stage biotech startups, particularly those in the pre-seed to Series A funding stages. The organization offers a fundraising-focused accelerator program called Transferase Accelerator, which includes workshops and access to a network of biotech investors, helping startups navigate the complexities of fundraising.
Value and support
Founders participating in the Transferase Accelerator program gain access to workshops and a network of biotech investors, enhancing their fundraising efforts and providing valuable insights into the biotech industry.
Terms and economics
- Indicative investment
- $250,000
Availability
- Application state
- Not published
Focus and fit
- Stages
- Pre-seed · Seed · Series A
- Sectors
- Biotech & Life Sciences
- Regions
- United KingdomUnited States
Alumni and track record
Alumni context
Notable alumni companies include Boston Bioprocess, Oxford SimCell, RiverWalk Therapeutics, and Imaginostics, which have made significant strides in their respective fields.
Common questions
What to know about Cephalo Ventures
Upseed classifies Cephalo Ventures under the Venture Capital organization type. Its current public profile includes funder and program host capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 3, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.